Seventy-three teams tested one hypothesis on the same data and reached opposite answers. The lesson is about method, not misconduct, and about making hidden choices visible.

In 2023 the whole editorial board of NeuroImage quit over fees and started a rival journal. Elsevier kept NeuroImage running with an interim board. The reputation was harder to keep.